Cannabis
Another Flawed Study On Cannabis Use Disorder
Cannabis use disorder isn’t defined medically, and doesn’t seem to cause real problems. However, despite not instigating societal harm; yet another study is out trying to warn us about the prevalence of cannabis use disorder.
What’s a use disorder?
Like any other psychiatric condition; what is termed as a ‘use disorder,’ has no medical diagnosis. A medical diagnosis is a proof by way of a definable metric or test. This automatically means having a use disorder is a diagnosis up to the discretion of a particular doctor. These definitions are meant to meet certain behavioral criteria; but the truth is that doctors disagree all the time on everything. Without medical backing; there is no confirmed consensus when talking about psychiatric diagnoses, even with DSM manuals.
According to the National Institute of Mental Health, the definition of a use disorder is “a treatable mental disorder that affects a person’s brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD.”
By definition, its all addiction, though; as the definition for addiction is the “compulsive drug seeking and use despite adverse consequences,” according to the National Institute on Drug Abuse. Why do these definitions overlap? Because there is no medical diagnosis defining each specifically. What it comes down to in either case, is an inability to control use.
There’s less debate over the existence of alcohol use disorder or opioid use disorder. They cause extreme damage to users and society at large; and we see it. We can watch those with the addiction, unable to control their use. Everyone likely knows someone who lost a job, or a spouse; or is dealing with an illness; or who got into some kind of an accident; because of drug use they could not control. The term ‘use disorder’ is easily understood in this context, as a behavior that is not only uncontrolled, but which causes problems.
Does cannabis use disorder exist?
Sure, if you’re only concerned about a manual made by a group nearly all associated with pharmaceutical companies; with the main purpose of prescribing psychotropic medication. The DSM manuals are by nature, full of ‘disorders,’ that have no medical definition.
As in, there is no test that can confirm a person is borderline, or schizophrenic, or suffering from a drug use disorder. Like it or not, there is no medical professional that can say there’s a medical diagnosis for cannabis use disorder. And realistically, there is no defined association between cannabis and large problems; in fact, so little, that after thousands of years of documented use, such damage cannot be explicitly pointed to. Do we question if alcohol causes problems? No!
As such, cannabis use disorder (CUD) is not medically defined, and cannot be tested for. Cannabis causes no actual addiction, so its not defined as an addictive drug. Nor does it cause damage to society; and any damage to one’s life, is minimal at best. Things like losing a job or spouse, or causing sickness or accidents; aren’t associated with cannabis like they are with other drugs. How many people do you know who were so out of control with weed, that they messed up their entire life?
For that matter, how many people do you know who are willing to prostitute themselves out for it, or choose weed over eating, or allow their children to be on the street so they can keep smoking up? This happens with alcohol, and meth, and opioids. It doesn’t with weed. Which indicates there is no use disorder attached. People, in fact, do not seem to have an issue not using weed, if there life calls for it. In other words; its uniformly not associated with behaviors that indicate a fundamental loss of control.
Perhaps the confusion is because unhappy people tend to keep doing things that make them feel better. This isn’t addiction, but self-treatment. Whereas this is problematic if it causes damage; it kind of isn’t, if it doesn’t. I’ve been using weed, and around weed smokers, for half my life. Never – literally not ever – have I met someone who has so much of an issue controlling themselves, that they cannot stop from smoking up. Not. One. Time. But I know a lot of alcoholics, smokers, and opioid users who lost their jobs, or families; who have extreme health issues; been in, or caused, accidents; or who overdosed and died.
New study on cannabis use disorder
Unfortunately, a lack of general logic or evidence over time, hasn’t stopped bad research from continually coming out on the topic. Even as this continues to make no sense, with nothing substantial backing it up in real life; article after article comes out to promote the idea that cannabis use disorder is a real thing. Case in point is this recent study.
The study is called Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal. The purpose was to investigate how prevalent cannabis use disorder is in a regular population, specifically in adult-use legal states. It also looked into whether there were different reasons for use between locations.
According to the writers, the results of the study on cannabis use disorder indicate that the reasons for use didn’t change between locations, but the rate of use did; going from moderate to severe in different places. Researchers conclude from their data that cannabis use disorder is prevalent in legal states, and that moderate and severe use is more common in non-medical patients, or those who use it for both recreational and medical purposes.
How did researchers come to this amazing conclusion that a lot of people smoke weed? They conducted an in-person study. The study consisted of 1,688 participants, out of an original pool of 5,000 possible participants. These 5,000 were picked randomly from a pool of 108,950 adults who underwent a screening for cannabis use, as part of a primary care visit. Investigators looked at the time period of March 2019 – September 2019. The chosen 5,000 were offered a survey for the study.
In terms of sample selection, more specifically, “Sample selection included patients who reported no past-year use as well as stratified oversampling of patients with more frequent cannabis use and patients of minoritized racial and ethnic groups (including American Indian or Alaska Native, Asian, Black, Hispanic, and Native Hawaiian or Other Pacific Islander) in order to obtain representation of subgroups that are often underrepresented in research.“
The survey looked at how often the participants used cannabis in the past year. Out of the 5,000, 1,688 filled out the survey and gave consent. Of these, 1463 said they used cannabis in the past 30 days. “Respondents were asked about past-year use and more specific questions about past 30-day use, including reasons, mode, and typical frequency of cannabis use.” Investigators continued that the results “weighted to the primary care sample who used cannabis in the past 30 days (hereafter, patients who used cannabis).”
Massive issues with this study
The biggest issue with this study, is in how the sample was collected. The study’s stated aim was to see how prevalent cannabis use disorder is within legal state populations. This indicates that the study group being examined should reflect as accurately as possible, the makeup of the actual population of these locations.
Researchers did not do this though, instead they used something called stratified oversampling, for both frequent users, and minority populations. This means they included a greater percentage of participants from these populations, than exist by percent in reality. If we were only looking at why people use, this is useful for gaining information from underrepresented minorities, or focusing on those who do it more. But when looking to assess overall use rates; oversampling any part of a population, means getting skewed results.
Simply creating a sample which does not correspond to the actual population, is a huge flaw. Especially when that means including more heavy users in a way that is already known to be disproportionate, and then saying that a use disorder is prevalent. The oversampling of minorities can theoretically be worked out to correspond to actual population statistics, although this won’t account for the uneven collection of information. But if the purpose is to assess use rates and issues of control; perhaps automatically adding in more heavy users, is a fundamentally bad idea.
If you’re going to focus on a certain level of use, that’s what you’ll see. The investigators purposefully added in more frequent weed users than existed by percent in their own collected data. And they did that for an investigation literally meant to measure how often people use weed frequently. This is problematic. How can a study measure the overall prevalence of weed use (or abuse), if the sample used to measure it, is automatically skewed toward higher use?
Conclusion
The reality is that its easy to find bad study results on cannabis use disorder and an array of other topics. So much so that its coming up as an issue because of studies getting retracted. Researchers are dying to get published, and that promotes flawed research like this. Writers want stories, and that means bad titles get passed on. It’s a bad cycle. And it continues.
Let’s remember, that after years of nonsensical reporting about cannabis causing psychosis, its now coming out that this was never true. What does that say for all the research that tried to scare us about inducing schizophrenia, and what does it say for those who created it? The idea of a cannabis use disorder might get pushed now; but that doesn’t mean it won’t be invalidated as people come to their senses.
Hello cannabis supporters! Thanks for being with us at Cannadelics.com; an independent publication looking to bring you eye-opening reporting of the cannabis and psychedelics spaces. Come our way frequently to keep up with the Joneses, and get yourself signed up to the Cannadelics Weekly Newsletter, so you’re always up on what’s going down.
Related
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
RELATED: Music Is A Turn On Like Sex And Marijuana
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
RELATED: Mike Johnson And Marijuana
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
RELATED: Marijuana Use And Guy’s Member
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
RELATED: Music Is A Turn On Like Sex And Marijuana
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.
White House Finally Comments On Marijuana Industry
Stop Using Bat Poop to Fertilize Your Weed Plants Immediately, Here is Why…
The History Behind April Fool’s Day
Star signs and cannabis strains: April 2025 horoscopes
Does Comfort Food Actually Help
Connect to cannabis history with three legacy strains from Paradise Seeds
This State’s Cannabis Revenue Keeps Pouring In
Major Bloom: Cultivating community, creativity, and cannabis in Worcester
How a Colorado operator stumbled onto ‘blueprint for laundering marijuana’
Northern Ireland: Man charged after £425,000 worth of cannabis seized
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing1 year agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse